Edition:
United States

Celcuity Inc (CELC.OQ)

CELC.OQ on NASDAQ Stock Exchange Capital Market

24.55USD
22 Jun 2018
Change (% chg)

$3.02 (+14.03%)
Prev Close
$21.53
Open
$21.69
Day's High
$24.65
Day's Low
$21.69
Volume
264,000
Avg. Vol
9,039
52-wk High
$24.65
52-wk Low
$11.10

Chart for

About

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)

Overall

Beta: --
Market Cap(Mil.): $248.12
Shares Outstanding(Mil.): 10.11
Dividend: --
Yield (%): --

Financials

  CELC.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -0.85 -- --
ROI: -43.84 -5.25 13.10
ROE: -43.84 -6.83 15.09

BRIEF-Celcuity Q1 Loss Per Share $0.19

* CELCUITY-INTERIM RESULTS OF CLINICAL TRIAL IN COLLABORATION WITH NSABP FOUNDATION, GENENTECH EXPECTED IN Q1 OR Q2 2019, INSTEAD OF 2018 END ANTICIPATED EARLIER Source text for Eikon: Further company coverage:

May 14 2018

BRIEF-Celcuity Reports Q4 Adjusted Non-Gaap Loss Per Share $0.14

* CELCUITY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 15 2018

Earnings vs. Estimates